The Chemours Company (CC) Stock Analysis

Chemours (CC) Misses Q3 Earnings and Revenue Estimates

Mon, November 2, 2026 at 11:10 PM UTC 2 min read

Chemours (CC) reported Q3 earnings of $0.21 per share, falling short of the Zacks Consensus Estimate of $0.26, and revenues of $1.54 billion, missing expectations by 0.11%. This marks a -19.23% earnings surprise, with the company not beating revenue estimates over the last four quarters. Despite a 14.8% gain in shares since the start of the year, the stock currently holds a Zacks Rank #4 (Sell), indicating potential underperformance in the near future.

Read full article →

Chemours Announces Fourth Quarter Dividend

Tue, October 27, 2026 at 8:30 PM UTC 2 min read

Chemours has declared a fourth-quarter dividend of $0.25 per share, reflecting the company's commitment to returning value to shareholders. This announcement is significant for investors as it underscores Chemours' strong financial position and consistent cash flow generation, which can enhance investor confidence and potentially attract more interest in the stock. The dividend payment is scheduled for December 15, 2023, to shareholders of record as of November 30, 2023.

Read full article →